Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen: http://dx.doi.org/10.25673/111297
Titel: Validation of clinical-radiological scores for prognosis of mortality in acute pulmonary embolism
Autor(en): Surov, AlexeyIn der Gemeinsamen Normdatei der DNB nachschlagen
Thormann, MaximilianIn der Gemeinsamen Normdatei der DNB nachschlagen
Bär, CarolineIn der Gemeinsamen Normdatei der DNB nachschlagen
Wienke, AndreasIn der Gemeinsamen Normdatei der DNB nachschlagen
Borggrefe, JanIn der Gemeinsamen Normdatei der DNB nachschlagen
Erscheinungsdatum: 2023
Art: Artikel
Sprache: Englisch
Zusammenfassung: Introduction: Acute pulmonary embolism (APE) is a hazardous disorder with a high mortality. Combination of clinical, radiological, and serological parameters can improve risk stratification of APE. Most of the proposed combined scores were not validated in independent cohorts. Our aim was to validate the proposed clinical-radiological scores for prognosis of 7- and 30-day mortality in APE. Materials and methods: Our sample comprised 531 patients with APE, mean age 64.8 ± 15.6 years, 221 (41.6%) females and 310 (58.4%) males. The following parameters were collected: Age and sex of the patients, mortality within the observation time of 30 days, simplified pulmonary embolism severity index (sPESI), pH troponin level (pg/ml), minimal systolic and diastolic blood pressures (mmHg), heart rate, O2 saturation, episodes of syncope, and need for vasopressors. On CT pulmonary angiography (CTPA), short axis ratio right ventricle/left ventricle (RV/LV), and reflux of contrast medium into the inferior vena cava were obtained. The following clinical-radiological scores were calculated: BOVA score, pulmonary embolism mortality score (PEMS), European Society of Cardiology (ESC) score, Kumamaru score, and Calgary acute pulmonary embolism (CAPE) score. Results: Overall, 31 patients (5.8%) died within seven and 64 patients (12%) within 30 days. All scores showed high negative prognostic values ranging from 89.0 to 99.0%. PEMS and CAPE score demonstrated the highest specificity for 7-day mortality (93.4% and 85.0%), PEMS and BOVA for 30-day mortality (94.2% and 90.4%). The highest sensitivity was observed for ESC 2019 (96.8% and 95.3%). Kumamaru and CAPE scores had low sensitivity. All scores had low positive and high negative predictive values. Conclusion: For prognosis of 7- and 30-day mortality in APE, PEMS score has the highest specificity. ESC 2019 shows the highest sensitivity. All scores had low positive and high negative predictive values.
URI: https://opendata.uni-halle.de//handle/1981185920/113251
http://dx.doi.org/10.25673/111297
Open-Access: Open-Access-Publikation
Nutzungslizenz: (CC BY 4.0) Creative Commons Namensnennung 4.0 International(CC BY 4.0) Creative Commons Namensnennung 4.0 International
Journal Titel: Respiratory research
Verlag: BioMed Central
Verlagsort: London
Band: 24
Originalveröffentlichung: 10.1186/s12931-023-02489-0
Seitenanfang: 1
Seitenende: 8
Enthalten in den Sammlungen:Open Access Publikationen der MLU

Dateien zu dieser Ressource:
Datei Beschreibung GrößeFormat 
s12931-023-02489-0.pdf1.36 MBAdobe PDFMiniaturbild
Öffnen/Anzeigen